Clinical Trial Update: High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose weekly carfilzomib with cyclophosphamide and dexamethasone in relapsed multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-03